These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25808736)
21. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Varadarajan J; McWilliams MJ; Hughes SH Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14747-52. PubMed ID: 23959861 [TBL] [Abstract][Full Text] [Related]
22. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262 [TBL] [Abstract][Full Text] [Related]
23. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment]. Llibre JM; Martínez-Picado J Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421 [TBL] [Abstract][Full Text] [Related]
24. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site. Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199 [TBL] [Abstract][Full Text] [Related]
25. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. Sinha S; Pursley MH; Grandgenett DP J Virol; 2002 Apr; 76(7):3105-13. PubMed ID: 11884535 [TBL] [Abstract][Full Text] [Related]
26. The second chance story of HIV-1 DNA: Unintegrated? Not a problem! Wu Y Retrovirology; 2008 Jul; 5():61. PubMed ID: 18613958 [TBL] [Abstract][Full Text] [Related]
27. Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models. Bonczkowski P; De Scheerder MA; Malatinkova E; Borch A; Melkova Z; Koenig R; De Spiegelaere W; Vandekerckhove L Sci Rep; 2016 Dec; 6():38329. PubMed ID: 27910923 [TBL] [Abstract][Full Text] [Related]
28. In vitro assays for activities of retroviral integrase. Chow SA Methods; 1997 Aug; 12(4):306-17. PubMed ID: 9245611 [TBL] [Abstract][Full Text] [Related]
30. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. Tasara T; Maga G; Hottiger MO; Hübscher U FEBS Lett; 2001 Oct; 507(1):39-44. PubMed ID: 11682056 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines. Nakajima N; Lu R; Engelman A J Virol; 2001 Sep; 75(17):7944-55. PubMed ID: 11483739 [TBL] [Abstract][Full Text] [Related]
32. Unprocessed viral DNA could be the primary target of the HIV-1 integrase inhibitor raltegravir. Ammar FF; Abdel-Azeim S; Zargarian L; Hobaika Z; Maroun RG; Fermandjian S PLoS One; 2012; 7(7):e40223. PubMed ID: 22768342 [TBL] [Abstract][Full Text] [Related]
33. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Vandegraaff N; Kumar R; Hocking H; Burke TR; Mills J; Rhodes D; Burrell CJ; Li P Antimicrob Agents Chemother; 2001 Sep; 45(9):2510-6. PubMed ID: 11502522 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the activity of HIV-1 integrase over-expressed in eukaryotic cells. Van Maele B; Van Eylen L; Pluymers W; Debyser Z Biochem Biophys Res Commun; 2005 Feb; 327(1):261-7. PubMed ID: 15629457 [TBL] [Abstract][Full Text] [Related]
35. The role of unintegrated DNA in HIV infection. Sloan RD; Wainberg MA Retrovirology; 2011 Jul; 8():52. PubMed ID: 21722380 [TBL] [Abstract][Full Text] [Related]
36. A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles. Delelis O; Petit C; Leh H; Mbemba G; Mouscadet JF; Sonigo P Retrovirology; 2005 May; 2():31. PubMed ID: 15904533 [TBL] [Abstract][Full Text] [Related]
37. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents. de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099 [TBL] [Abstract][Full Text] [Related]
38. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521 [TBL] [Abstract][Full Text] [Related]
39. Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive update. Hamid FB; Kim J; Shin CG AIDS Res Ther; 2017 Feb; 14(1):9. PubMed ID: 28209198 [TBL] [Abstract][Full Text] [Related]
40. Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir. Ebina H; Kanemura Y; Suzuki Y; Urata K; Misawa N; Koyanagi Y Virology; 2012 May; 427(1):44-50. PubMed ID: 22374236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]